1 completed, 1 withdrawn. 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 1, Withdrawn 1 |
Follow Stage IIIA Hilar Cholangiocarcinoma: new trials by email Literature Review of Stage IIIA Hilar Cholangiocarcinoma trials Research Report on Stage IIIA Hilar Cholangiocarcinoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Ricolinostat, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients With Unresectable or Metastatic Cholangiocarcinoma Cisplatin, Gemcitabine Hydrochloride, Laboratory Biomarker Analysis - Non-Resectable Cholangiocarcinoma, Recurrent Cholangiocarcinoma | Phase 1 | Withdrawn | Mayo Clinic | 2017-05-01 | 2017-05-30 | |
| ADH-1, Gemcitabine Hydrochloride & Cisplatin in Treating Metastatic Pancreatic or Biliary Tract Cancer ADH-1, Cisplatin, Gemcitabine Hydrochloride - Ampulla of Vater Adenocarcinoma, Gallbladder Adenocarcinoma | Phase 1 | Completed | University of Nebraska | 17 | 2013-04-09 | 2023-12-28 |
Cholangiocarcinoma (2) · Klatskin Tumor (2) · Bile Duct Neoplasms (1) · Gallbladder Neoplasms (1) · Pancreatic Neoplasms (1)
Adenocarcinoma (2) · Biliary Tract Diseases (2) · Biliary Tract Neoplasms (2) · Carcinoma (2) · Digestive System Diseases (2) · Digestive System Neoplasms (2) · Neoplasms (2) · Neoplasms by Histologic Type (2) · Neoplasms by Site (2) · Neoplasms, Glandular and Epithelial (2) · Bile Duct Diseases (1) · Endocrine Gland Neoplasms (1) · Endocrine System Diseases (1) · Gallbladder Diseases (1) · Pancreatic Diseases (1)
1,2-diaminocyclohexaneplatinum II citrate (2) · Cisplatin (2) · Gemcitabine (2) · Platinum (2) · N-Ac-CHAVC-NH2 (1) · ricolinostat (1)
Mayo Clinic (1) · University of Nebraska (1)
United States (2)
Jean L Grem, MD (1) · Kabir Mody (1)
P30CA015083 (1), P30CA036727 (1), P50CA127297 (1)